7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Report: not found

      Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model

      report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Rhabdomyosarcoma (RMS) is a rare mesenchymal tumor. The aim of the present study was to develop a patient-derived orthotopic xenograft (PDOX) mouse model of RMS and compare the PDOX model to a subcutaneous (s.c.)-transplant model. A patient RMS from a striated muscle was grown orthotopically in the right biceps femoris muscle and right quadriceps muscle of nude mice to establish a PDOX model, as well as under the skin to establish an s.c. model. PDOX tumors grew at a statistically-significant faster rate compared to the s.c. tumors. Recurrence after surgical resection occurred only in PDOX tumors, not in the s.c. model. Histologically, only the PDOX model was shown to be invasive. In conclusion, these results indicate that the PDOX model of adult RMS is malignant and the subcutaneous model is benign. These results emphasize that a proper tumor microenvironment is necessary for patient-like behavior of a tumor in a mouse model.

          Related collections

          Author and article information

          Journal
          Cell Cycle
          Cell Cycle
          KCCY
          kccy20
          Cell Cycle
          Taylor & Francis
          1538-4101
          1551-4005
          2017
          10 November 2016
          : 16
          : 1
          : 91-94
          Affiliations
          [a ] AntiCancer, Inc. , San Diego, CA, USA
          [b ] Department of Surgery, University of California , San Diego, CA, USA
          [c ] Department of orthopedic Surgery, Kanazawa University , Kanazawa, Japa
          [d ] Department of Pathology, University of California , Los Angeles, CA, USA
          [e ] Division of Hematology-Oncology, University of California , Los Angeles, CA, USA
          [f ] Division of Surgical Oncology, University of California , Los Angeles, CA, USA
          Author notes
          CONTACT Fritz C. Eilber, MD fceilber@ 123456mednet.ucla.edu Associate Professor of Surgery, Associate Professor of Molecular & Medical Pharmacology UCLA, Division of Surgical Oncology , 10833 LeConte Avenue, Rm. 54-140 CHS, Los Angeles, CA 90095-1782, USA
          Robert M. Hoffman, PhD all@ 123456anticancer.com AntiCancer, Inc. , 7917 Ostrow St., San Diego, CA 92111, USA

          Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/kccy.

          This article is dedicated to the memory of A.R. Moossa, MD and Sun Lee, MD.

          Author information
          http://orcid.org/0000-0003-3336-9333
          Article
          PMC5270546 PMC5270546 5270546 1252885
          10.1080/15384101.2016.1252885
          5270546
          27830986
          ff61748c-03a2-4fb9-8f40-4d3933e27572
          © 2017 Taylor & Francis
          History
          : 19 September 2016
          : 19 October 2016
          Page count
          Figures: 4, Tables: 0, References: 28, Pages: 4
          Categories
          Report

          muscle,nude mouse,patient-derived orthotopic xenograft,PDOX,rhabdomyosarcoma,resection,recurrence,subcutaneous,tumor growth rate

          Comments

          Comment on this article